with conventional cross-protection (14). Conventional crossprotection was found to be essentially ineffective against challenge by CMV containing a necrogenic CARNA 5 (6; M. S. Montasser, unpublished data); however, it has been shown to be effective against satellite RNA-free CMV strains (2) but not as effective against a very severe satellite RNA-free strain as is protection by CMV + satellite RNA (14).